Search results
Results from the WOW.Com Content Network
Europe and other parts of the world use the ICD-10. The root codes for ICD-10 and ICD-10-CM are the same, making it helpful for locating codes for general body systems and disease processes. [2] [3] In ICD-11 the search and coding of any disease, including rare ones is done via the ICD-11 website. [4]
Chondrosarcoma is a bone sarcoma, a primary cancer composed of cells derived from transformed cells that produce cartilage. [1] A chondrosarcoma is a member of a category of tumors of bone and soft tissue known as sarcomas. About 30% of bone sarcomas are chondrosarcomas. [2] It is resistant to chemotherapy and radiotherapy. Unlike other primary ...
The incidence of a secondary chondrosarcoma in Ollier disease is most commonly approximated at 25–30% with some projections even as high as 50%. [ 11 ] [ 12 ] [ 13 ] Chondrosarcomas are typically developed during young adulthood and mostly form as a unifocal distribution in Ollier disease patients. [ 3 ]
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries. It is currently in its third revision (ICD-O-3). ICD-10 includes a list of ...
10–19 Muscle (smooth) Leiomyosarcoma Trunk 15-35+ Fibrous tissue Undifferentiated pleomorphic sarcoma Legs 15–19+ Dermatofibrosarcoma protuberans Trunk 15–19 Synovial sarcoma Legs, arms, and trunk 15–35 Fat Liposarcoma Arms and Legs 15–19+ Peripheral nerves Malignant peripheral nerve sheath tumors (also called neurofibrosarcomas)
Indications for external hemipelvectomy include neoplastic extension into the sciatic nerve, where loss of function of the lower extremity is anticipated. [1] Internal hemipelvectomy is preferred when complete resection of the tumor is possible without sacrificing the lower extremity. [ 1 ]
The ICD-10 Clinical Modification (ICD-10-CM) is a set of diagnosis codes used in the United States of America. [1] It was developed by a component of the U.S. Department of Health and Human services, [ 2 ] as an adaption of the ICD-10 with authorization from the World Health Organization .
EMC was firstly described in 1953 by Stout et al. when they discussed the different species of extraskeletal chondrosarcoma, [2] but EMC concept was firstly proposed in 1972 by Enzinger et al. [3] Brody thought that this was a unique low-grade malignancy with a low growth rate and both clinically and histopathologically distinct anamnesis beside the typical chondrosarcomas. [4]